What should be the laboratory approach against isolated prolongation of a activated partial thromboplastin time?
Background This study is a retrospective evaluation of patients who were subject to mixing study in our laboratory due to prolonged APTT. The preliminary diagnoses, clinical manifestations, and results of additional ordered tests were reviewed. The study aims to investigate whether repeating APTT te...
Saved in:
Published in | Journal of clinical laboratory analysis Vol. 32; no. 6; pp. e22415 - n/a |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
John Wiley & Sons, Inc
01.07.2018
John Wiley and Sons Inc |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Background
This study is a retrospective evaluation of patients who were subject to mixing study in our laboratory due to prolonged APTT. The preliminary diagnoses, clinical manifestations, and results of additional ordered tests were reviewed. The study aims to investigate whether repeating APTT test with a different assay prior to performing mixed study in patients with prolonged APTT would be a better alternative algorithmic approach in order to save both time and costs.
Methods
We retrospectively evaluated 166 patients (65 females and 101 males) who were subject to mixing study due to isolated prolonged APTT. Additional ordered tests to identify the etiology and clinical findings were reviewed. All patients who had prolonged APTT as a result of testing with Hemosil Synthasil APTT reagent in ACL TOP analyzer were repeated with Stago Cephascreen APTT reagent in STA‐R coagulation analyzer.
Results
APTT test was requested preoperatively in 72.2% of cases. Only 6.6% of the cases had history of bleeding. Correction with mixing study was achieved in 122 (73.5%) cases, among which 75 (45%) cases were found to have APTT test results within reference range when tested with Cephascreen reagent. In 44 (26.5%) cases, mixing study did not result in correction. Only 4 cases were confirmed to have lupus anticoagulants (LA), while 4 cases were diagnosed with hemophilia with inhibitors.
Conclusion
Prolonged APTT results should always be retested using a different assay prior to mixing study. The clinician and the laboratory specialist should collaborate at the postanalytical phase. |
---|---|
AbstractList | BackgroundThis study is a retrospective evaluation of patients who were subject to mixing study in our laboratory due to prolonged APTT. The preliminary diagnoses, clinical manifestations, and results of additional ordered tests were reviewed. The study aims to investigate whether repeating APTT test with a different assay prior to performing mixed study in patients with prolonged APTT would be a better alternative algorithmic approach in order to save both time and costs.MethodsWe retrospectively evaluated 166 patients (65 females and 101 males) who were subject to mixing study due to isolated prolonged APTT. Additional ordered tests to identify the etiology and clinical findings were reviewed. All patients who had prolonged APTT as a result of testing with Hemosil Synthasil APTT reagent in ACL TOP analyzer were repeated with Stago Cephascreen APTT reagent in STA‐R coagulation analyzer.ResultsAPTT test was requested preoperatively in 72.2% of cases. Only 6.6% of the cases had history of bleeding. Correction with mixing study was achieved in 122 (73.5%) cases, among which 75 (45%) cases were found to have APTT test results within reference range when tested with Cephascreen reagent. In 44 (26.5%) cases, mixing study did not result in correction. Only 4 cases were confirmed to have lupus anticoagulants (LA), while 4 cases were diagnosed with hemophilia with inhibitors.ConclusionProlonged APTT results should always be retested using a different assay prior to mixing study. The clinician and the laboratory specialist should collaborate at the postanalytical phase. Background This study is a retrospective evaluation of patients who were subject to mixing study in our laboratory due to prolonged APTT. The preliminary diagnoses, clinical manifestations, and results of additional ordered tests were reviewed. The study aims to investigate whether repeating APTT test with a different assay prior to performing mixed study in patients with prolonged APTT would be a better alternative algorithmic approach in order to save both time and costs. Methods We retrospectively evaluated 166 patients (65 females and 101 males) who were subject to mixing study due to isolated prolonged APTT. Additional ordered tests to identify the etiology and clinical findings were reviewed. All patients who had prolonged APTT as a result of testing with Hemosil Synthasil APTT reagent in ACL TOP analyzer were repeated with Stago Cephascreen APTT reagent in STA‐R coagulation analyzer. Results APTT test was requested preoperatively in 72.2% of cases. Only 6.6% of the cases had history of bleeding. Correction with mixing study was achieved in 122 (73.5%) cases, among which 75 (45%) cases were found to have APTT test results within reference range when tested with Cephascreen reagent. In 44 (26.5%) cases, mixing study did not result in correction. Only 4 cases were confirmed to have lupus anticoagulants (LA), while 4 cases were diagnosed with hemophilia with inhibitors. Conclusion Prolonged APTT results should always be retested using a different assay prior to mixing study. The clinician and the laboratory specialist should collaborate at the postanalytical phase. This study is a retrospective evaluation of patients who were subject to mixing study in our laboratory due to prolonged APTT. The preliminary diagnoses, clinical manifestations, and results of additional ordered tests were reviewed. The study aims to investigate whether repeating APTT test with a different assay prior to performing mixed study in patients with prolonged APTT would be a better alternative algorithmic approach in order to save both time and costs. We retrospectively evaluated 166 patients (65 females and 101 males) who were subject to mixing study due to isolated prolonged APTT. Additional ordered tests to identify the etiology and clinical findings were reviewed. All patients who had prolonged APTT as a result of testing with Hemosil Synthasil APTT reagent in ACL TOP analyzer were repeated with Stago Cephascreen APTT reagent in STA-R coagulation analyzer. APTT test was requested preoperatively in 72.2% of cases. Only 6.6% of the cases had history of bleeding. Correction with mixing study was achieved in 122 (73.5%) cases, among which 75 (45%) cases were found to have APTT test results within reference range when tested with Cephascreen reagent. In 44 (26.5%) cases, mixing study did not result in correction. Only 4 cases were confirmed to have lupus anticoagulants (LA), while 4 cases were diagnosed with hemophilia with inhibitors. Prolonged APTT results should always be retested using a different assay prior to mixing study. The clinician and the laboratory specialist should collaborate at the postanalytical phase. This study is a retrospective evaluation of patients who were subject to mixing study in our laboratory due to prolonged APTT. The preliminary diagnoses, clinical manifestations, and results of additional ordered tests were reviewed. The study aims to investigate whether repeating APTT test with a different assay prior to performing mixed study in patients with prolonged APTT would be a better alternative algorithmic approach in order to save both time and costs.BACKGROUNDThis study is a retrospective evaluation of patients who were subject to mixing study in our laboratory due to prolonged APTT. The preliminary diagnoses, clinical manifestations, and results of additional ordered tests were reviewed. The study aims to investigate whether repeating APTT test with a different assay prior to performing mixed study in patients with prolonged APTT would be a better alternative algorithmic approach in order to save both time and costs.We retrospectively evaluated 166 patients (65 females and 101 males) who were subject to mixing study due to isolated prolonged APTT. Additional ordered tests to identify the etiology and clinical findings were reviewed. All patients who had prolonged APTT as a result of testing with Hemosil Synthasil APTT reagent in ACL TOP analyzer were repeated with Stago Cephascreen APTT reagent in STA-R coagulation analyzer.METHODSWe retrospectively evaluated 166 patients (65 females and 101 males) who were subject to mixing study due to isolated prolonged APTT. Additional ordered tests to identify the etiology and clinical findings were reviewed. All patients who had prolonged APTT as a result of testing with Hemosil Synthasil APTT reagent in ACL TOP analyzer were repeated with Stago Cephascreen APTT reagent in STA-R coagulation analyzer.APTT test was requested preoperatively in 72.2% of cases. Only 6.6% of the cases had history of bleeding. Correction with mixing study was achieved in 122 (73.5%) cases, among which 75 (45%) cases were found to have APTT test results within reference range when tested with Cephascreen reagent. In 44 (26.5%) cases, mixing study did not result in correction. Only 4 cases were confirmed to have lupus anticoagulants (LA), while 4 cases were diagnosed with hemophilia with inhibitors.RESULTSAPTT test was requested preoperatively in 72.2% of cases. Only 6.6% of the cases had history of bleeding. Correction with mixing study was achieved in 122 (73.5%) cases, among which 75 (45%) cases were found to have APTT test results within reference range when tested with Cephascreen reagent. In 44 (26.5%) cases, mixing study did not result in correction. Only 4 cases were confirmed to have lupus anticoagulants (LA), while 4 cases were diagnosed with hemophilia with inhibitors.Prolonged APTT results should always be retested using a different assay prior to mixing study. The clinician and the laboratory specialist should collaborate at the postanalytical phase.CONCLUSIONProlonged APTT results should always be retested using a different assay prior to mixing study. The clinician and the laboratory specialist should collaborate at the postanalytical phase. |
Author | Nazaroglu, Namik K. Senes, Mehmet Pekin, Melike Falay, Mesude Yücel, Dogan Turhan, Turan Özet, Gülsüm Dagdaş, Simten |
AuthorAffiliation | 3 Department of Medical Biochemistry Ankara Numune Training and Research Hospital Ankara Turkey 1 Department of Hematology Ankara Numune Training and Research Hospital Ankara Turkey 2 Department of Medical Biochemistry Ankara Training and Research Hospital Ankara Turkey 4 Synlab Laboratories Ankara Turkey |
AuthorAffiliation_xml | – name: 3 Department of Medical Biochemistry Ankara Numune Training and Research Hospital Ankara Turkey – name: 2 Department of Medical Biochemistry Ankara Training and Research Hospital Ankara Turkey – name: 4 Synlab Laboratories Ankara Turkey – name: 1 Department of Hematology Ankara Numune Training and Research Hospital Ankara Turkey |
Author_xml | – sequence: 1 givenname: Mesude orcidid: 0000-0001-7846-3476 surname: Falay fullname: Falay, Mesude email: mesudey@gmail.com organization: Ankara Numune Training and Research Hospital – sequence: 2 givenname: Mehmet surname: Senes fullname: Senes, Mehmet organization: Ankara Training and Research Hospital – sequence: 3 givenname: Dogan surname: Yücel fullname: Yücel, Dogan organization: Ankara Training and Research Hospital – sequence: 4 givenname: Turan surname: Turhan fullname: Turhan, Turan organization: Ankara Numune Training and Research Hospital – sequence: 5 givenname: Simten surname: Dagdaş fullname: Dagdaş, Simten organization: Ankara Numune Training and Research Hospital – sequence: 6 givenname: Melike surname: Pekin fullname: Pekin, Melike organization: Ankara Numune Training and Research Hospital – sequence: 7 givenname: Namik K. surname: Nazaroglu fullname: Nazaroglu, Namik K. organization: Synlab Laboratories – sequence: 8 givenname: Gülsüm surname: Özet fullname: Özet, Gülsüm organization: Ankara Numune Training and Research Hospital |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/29484705$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kV9rFDEUxYNU7Lb64geQgC9SmJpkJzOZF0tZrH9Y8EXxMdxkMjtZMpMxyVT225vt1KJFzEsg93cO5-acoZPRjwahl5RcUkLY2712cMlYSfkTtKKkEQUTjJ-gFRGiLgSh61N0FuOeECIaWj1Dp6wpRVkTvkLT9x4Sjr2fXYuVwak32IHyAZIPBwzTFDzoHsMO7BgTttE7SKbF-d35cQfJ-hH7DgMGneztMoOQLLhsFvyg_OQgJjviZAdz9Rw97cBF8-L-Pkffbt5_3Xwstl8-fNpcbwtdloIXqtVU6IZ3ptRCKyFAtMJ0mpeN6epa0aoBrQgnigGsa055J1hXcQKcger4-hy9W3ynWQ2m1WZMAZycgh0gHKQHK_-ejLaXO38rK5G9RZkN3twbBP9jNjHJwUZtnIPR-DlKln8zn4bWGX39CN37OYx5vUzVpFpzyo6JXv2Z6CHK7zIycLEAOvgYg-keEErksWl5bFreNZ1h8gjWNt21kbex7t8Sukh-WmcO_zGXnzfb60XzC6whviA |
CitedBy_id | crossref_primary_10_1111_ijlh_13818 crossref_primary_10_1155_2018_7185263 crossref_primary_10_1093_labmed_lmae053 crossref_primary_10_1097_MBC_0000000000001155 crossref_primary_10_1111_hae_13587 crossref_primary_10_1111_ijlh_12910 |
Cites_doi | 10.4065/82.7.864 10.1111/ejh.12634 10.1055/s-0033-1336832 10.1111/anae.12919 10.1515/cclm-2012-0387 10.1016/j.autrev.2013.08.001 10.1055/s-0028-1104539 10.1515/CCLM.2011.126 10.1002/ajh.23285 10.1055/s-0036-1571311 10.1111/j.1751-553X.2010.01261.x 10.1055/s-0033-1364187 10.1309/AJCP3J1ZKYBFQXJM 10.1182/blood-2003-03-0941 10.1111/ijlh.12025 10.1111/j.1751-553X.2008.01111.x 10.1111/ijlh.12415 10.1515/cclm-2014-1183 10.1111/ijlh.12206 10.1515/cclm-2014-0767 |
ContentType | Journal Article |
Copyright | 2018 Wiley Periodicals, Inc. Copyright © 2018 Wiley Periodicals, Inc. |
Copyright_xml | – notice: 2018 Wiley Periodicals, Inc. – notice: Copyright © 2018 Wiley Periodicals, Inc. |
DBID | AAYXX CITATION NPM 7QP 7T5 7U9 H94 K9. 7X8 5PM |
DOI | 10.1002/jcla.22415 |
DatabaseName | CrossRef PubMed Calcium & Calcified Tissue Abstracts Immunology Abstracts Virology and AIDS Abstracts AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef PubMed AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Immunology Abstracts Virology and AIDS Abstracts Calcium & Calcified Tissue Abstracts MEDLINE - Academic |
DatabaseTitleList | AIDS and Cancer Research Abstracts PubMed MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
DocumentTitleAlternate | FALAY et al |
EISSN | 1098-2825 |
EndPage | n/a |
ExternalDocumentID | PMC6816984 29484705 10_1002_jcla_22415 JCLA22415 |
Genre | shortCommunication Journal Article |
GroupedDBID | --- .3N .GA .GJ .Y3 05W 0R~ 10A 1L6 1OB 1OC 1ZS 24P 31~ 33P 3SF 3WU 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5GY 5RE 5VS 66C 6PF 702 7PT 7X7 8-0 8-1 8-3 8-4 8-5 8C1 8FI 8FJ 8UM 930 A01 A03 A8Z AAESR AAEVG AAHHS AANHP AAONW AAWTL AAZKR ABCQN ABEML ABIJN ABPVW ABUWG ACBWZ ACCFJ ACCMX ACGFS ACMXC ACPRK ACRPL ACSCC ACXQS ACYXJ ADBBV ADEOM ADIZJ ADKYN ADNMO ADPDF ADZMN AEEZP AEIMD AENEX AEQDE AEUQT AFBPY AFKRA AFPWT AFZJQ AHMBA AIWBW AJBDE ALAGY ALIPV ALMA_UNASSIGNED_HOLDINGS ALUQN AMBMR ASPBG ATUGU AVUZU AVWKF AZBYB AZFZN AZVAB BAFTC BBNVY BCNDV BDRZF BENPR BFHJK BHBCM BHPHI BMXJE BROTX BRXPI BY8 CCPQU CS3 D-6 D-7 D-E D-F DCZOG DPXWK DR2 DU5 DUUFO EBD EBS EJD EMOBN F00 F01 F04 F1Z F5P FEDTE FUBAC FYUFA G-S G.N GNP GODZA GROUPED_DOAJ H.X HBH HCIFZ HF~ HHY HMCUK HVGLF HYE HZ~ IAO IHR ITC IX1 J0M JPC KQQ LAW LC2 LC3 LH4 LITHE LOXES LP6 LP7 LUTES LW6 M65 M7P MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM N04 N05 N9A NF~ NNB O66 O9- OIG OK1 OVD OVEED P2P P2W P2X P2Z P4B P4D PALCI PIMPY PQQKQ Q.N Q11 QB0 QRW R.K RGB RIWAO RJQFR ROL RPM RWI RX1 SAMSI SUPJJ SV3 TEORI TWZ UB1 UKHRP V2E W8V W99 WBKPD WHWMO WIB WIH WIJ WIK WIN WOHZO WQJ WRC WUP WVDHM WXI WXSBR XG1 XPP XV2 ~IA ~WT AAYXX AGQPQ CITATION PHGZM PHGZT NPM 7QP 7T5 7U9 AAMMB AEFGJ AGXDD AIDQK AIDYY H94 K9. 7X8 5PM |
ID | FETCH-LOGICAL-c4485-bdc18c95fe4c8cb88a8d8efc549ef77b169acb050b2aa37515f82f650a52abf53 |
IEDL.DBID | DR2 |
ISSN | 0887-8013 1098-2825 |
IngestDate | Thu Aug 21 14:01:35 EDT 2025 Fri Jul 11 06:35:51 EDT 2025 Wed Aug 13 06:10:44 EDT 2025 Thu Apr 03 07:02:21 EDT 2025 Tue Jul 01 00:21:34 EDT 2025 Thu Apr 24 23:10:25 EDT 2025 Wed Jan 22 16:22:41 EST 2025 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 6 |
Keywords | mixing test APTT coagulation |
Language | English |
License | http://onlinelibrary.wiley.com/termsAndConditions#vor 2018 Wiley Periodicals, Inc. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c4485-bdc18c95fe4c8cb88a8d8efc549ef77b169acb050b2aa37515f82f650a52abf53 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ORCID | 0000-0001-7846-3476 |
OpenAccessLink | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/jcla.22415 |
PMID | 29484705 |
PQID | 2070635125 |
PQPubID | 105667 |
PageCount | 6 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_6816984 proquest_miscellaneous_2008888917 proquest_journals_2070635125 pubmed_primary_29484705 crossref_primary_10_1002_jcla_22415 crossref_citationtrail_10_1002_jcla_22415 wiley_primary_10_1002_jcla_22415_JCLA22415 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | July 2018 |
PublicationDateYYYYMMDD | 2018-07-01 |
PublicationDate_xml | – month: 07 year: 2018 text: July 2018 |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States – name: New York – name: Hoboken |
PublicationTitle | Journal of clinical laboratory analysis |
PublicationTitleAlternate | J Clin Lab Anal |
PublicationYear | 2018 |
Publisher | John Wiley & Sons, Inc John Wiley and Sons Inc |
Publisher_xml | – name: John Wiley & Sons, Inc – name: John Wiley and Sons Inc |
References | 2015; 37 2010; 32 2013; 39 2013; 88 2015; 70 2013; 35 2015; 53 2013; 51 2016; 42 2008 2008; 34 2011; 33 2016; 96 2014; 13 2007; 82 2014 2014; 40 2012; 137 2011; 49 2003; 102 e_1_2_5_15_1 e_1_2_5_14_1 e_1_2_5_17_1 e_1_2_5_9_1 e_1_2_5_16_1 e_1_2_5_8_1 e_1_2_5_11_1 e_1_2_5_23_1 e_1_2_5_7_1 e_1_2_5_10_1 e_1_2_5_6_1 e_1_2_5_13_1 e_1_2_5_21_1 e_1_2_5_5_1 e_1_2_5_12_1 e_1_2_5_22_1 e_1_2_5_4_1 e_1_2_5_3_1 e_1_2_5_2_1 e_1_2_5_19_1 e_1_2_5_18_1 e_1_2_5_20_1 |
References_xml | – volume: 34 start-page: 604 year: 2008 end-page: 611 article-title: Activated partial thromboplastin time: new tricks for an old dogma publication-title: Semin Thromb Hemost – volume: 40 start-page: 195 year: 2014 end-page: 204 article-title: Algorithmic approaches to hemostasis testing publication-title: Semin Thromb Hemost – volume: 32 start-page: 33 issue: 1p2 year: 2010 end-page: 39 article-title: Discrepancies between APTT results determined with different evaluation modes on automated coagulation analyzers publication-title: Int J Lab Hematol. – volume: 35 start-page: 177 year: 2013 end-page: 182 article-title: Investigation of prolonged APTT. Different approaches taken by laboratories to achieve the same diagnosis publication-title: Int J Lab Hematol – volume: 70 start-page: 68 year: 2015 end-page: 72 article-title: Laboratory monitoring of haemostasis publication-title: Anaesthesia – volume: 37 start-page: 8 year: 2015 end-page: 13 article-title: Clinical implications of clotting screens publication-title: Int J Lab Hematol – year: 2008 – volume: 13 start-page: 40 year: 2014 end-page: 48 article-title: Autoantibodies to coagulation factors: from pathophysiology to diagnosis and therapy publication-title: Autoimmun Rev – volume: 53 start-page: 1593 year: 2015 end-page: 1603 article-title: An international study of how laboratories handle and evaluate patient samples after detecting an unexpected APTT prolongation publication-title: Clin Chem Lab Med – volume: 42 start-page: 471 year: 2016 end-page: 477 article-title: Diagnostics of inherited bleeding disorders of secondary hemostasis: an easy guide for routine clinical laboratories publication-title: Semin Thromb Hemost – volume: 53 start-page: 185 year: 2015 end-page: 197 article-title: Recent guidelines and recommendations for laboratory assessment of the direct oral anticoagulants (DOACs): is there consensus? publication-title: Clin Chem Lab Med – volume: 82 start-page: 864 year: 2007 end-page: 873 article-title: How to interpret and pursue an abnormal prothrombin time, activated partial thromboplastin time, and bleeding time in adults publication-title: Mayo Clin Proc – volume: 51 start-page: 91 year: 2013 end-page: 97 article-title: Laboratory hemostasis: milestones in Clinical Chemistry and Laboratory Medicine publication-title: Clin Chem Lab Med – volume: 102 start-page: 2358 year: 2003 end-page: 2363 article-title: Cost of care and quality of life for patients with hemophilia complicated by inhibitors: the COCIS Study Group publication-title: Blood – volume: 37 start-page: e170 year: 2015 end-page: e171 article-title: Coagulopathy of sepsis from nonspecific inhibitors publication-title: Int J Lab Hematol – volume: 49 start-page: 755 year: 2011 end-page: 757 article-title: Laboratory testing and/or monitoring of the new oral anticoagulants/antithrombotics: for and against ? publication-title: Clin Chem Lab Med – year: 2014 – volume: 39 start-page: 283 year: 2013 end-page: 290 article-title: Mixing tests: diagnostic aides in the investigation of prolonged prothrombin times and activated partial thromboplastin times publication-title: Semin Thromb Hemost – volume: 137 start-page: 904 year: 2012 end-page: 908 article-title: Recommendations for appropriate activated partial thromboplastin time reagent selection and utilization publication-title: Am J Clin Pathol – volume: 33 start-page: 154 year: 2011 end-page: 158 article-title: The responsiveness of different APTT reagents to mild factor VIII, IX and XI deficiencies publication-title: Int J Lab Hematol – volume: 96 start-page: 578 year: 2016 end-page: 585 article-title: Applying a direct aPTT ratio (PlatelinLS/ActinFS) permits to identify rapidly and reliably a bleeding‐related factor deficiency or a lupus anticoagulant sequential to an isolated prolongation of aPTT in paediatric pre‐operative screening publication-title: Eur J Haematol – volume: 88 start-page: 82 year: 2013 end-page: 85 article-title: The isolated prolonged PTT publication-title: Am J Hematol – ident: e_1_2_5_6_1 doi: 10.4065/82.7.864 – ident: e_1_2_5_23_1 doi: 10.1111/ejh.12634 – ident: e_1_2_5_2_1 doi: 10.1055/s-0033-1336832 – ident: e_1_2_5_4_1 doi: 10.1111/anae.12919 – ident: e_1_2_5_12_1 doi: 10.1515/cclm-2012-0387 – ident: e_1_2_5_13_1 – ident: e_1_2_5_9_1 doi: 10.1016/j.autrev.2013.08.001 – ident: e_1_2_5_19_1 doi: 10.1055/s-0028-1104539 – ident: e_1_2_5_17_1 doi: 10.1515/CCLM.2011.126 – ident: e_1_2_5_22_1 doi: 10.1002/ajh.23285 – ident: e_1_2_5_11_1 doi: 10.1055/s-0036-1571311 – ident: e_1_2_5_21_1 doi: 10.1111/j.1751-553X.2010.01261.x – ident: e_1_2_5_5_1 doi: 10.1055/s-0033-1364187 – ident: e_1_2_5_7_1 doi: 10.1309/AJCP3J1ZKYBFQXJM – ident: e_1_2_5_15_1 doi: 10.1182/blood-2003-03-0941 – ident: e_1_2_5_3_1 doi: 10.1111/ijlh.12025 – ident: e_1_2_5_20_1 doi: 10.1111/j.1751-553X.2008.01111.x – ident: e_1_2_5_10_1 doi: 10.1111/ijlh.12415 – ident: e_1_2_5_8_1 doi: 10.1515/cclm-2014-1183 – ident: e_1_2_5_14_1 – ident: e_1_2_5_16_1 doi: 10.1111/ijlh.12206 – ident: e_1_2_5_18_1 doi: 10.1515/cclm-2014-0767 |
SSID | ssj0008916 |
Score | 2.1801827 |
Snippet | Background
This study is a retrospective evaluation of patients who were subject to mixing study in our laboratory due to prolonged APTT. The preliminary... This study is a retrospective evaluation of patients who were subject to mixing study in our laboratory due to prolonged APTT. The preliminary diagnoses,... BackgroundThis study is a retrospective evaluation of patients who were subject to mixing study in our laboratory due to prolonged APTT. The preliminary... |
SourceID | pubmedcentral proquest pubmed crossref wiley |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | e22415 |
SubjectTerms | Anticoagulants APTT Brief Report coagulation Etiology Hemophilia Laboratories mixing test Thromboplastin |
Title | What should be the laboratory approach against isolated prolongation of a activated partial thromboplastin time? |
URI | https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fjcla.22415 https://www.ncbi.nlm.nih.gov/pubmed/29484705 https://www.proquest.com/docview/2070635125 https://www.proquest.com/docview/2008888917 https://pubmed.ncbi.nlm.nih.gov/PMC6816984 |
Volume | 32 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1JS8QwFH6IB_HivtSNiF4UOk7TLQVBRBQR9SAKXqQkmURHx3ZwZgT99b6kyzgqgvZQSpOQNP1e3pc2-R7AtpYy9qWn3YTiKaBau1zzwPVUpIWgCZJis9_54jI6vQnObsPbMdiv9sIU-hD1BzdjGXa8NgbORW9vKBr6KDu8YR0QDsBmsZZhRFdD7SiW2Lin1opwGPZrbVK6Nyw66o2-UczvKyU_M1jrgk6m4a5qfLHy5Kkx6IuGfP-i6_jfp5uBqZKbksMCTLMwprI5mLgo_77PQ9fofJPeg4mKTYQiyB1JCaL85Y1U8uSE3_M2sk7SRlwjlW0RvN_Js3sLApJrwonZTvFapBnsYq0mXsOzyLvI5vvtjJiY9wcLcHNyfH106pYRG1yJ07zQFS3pMZmEWgWSScEYZy2mtMRJqNJxLLwo4VI0w6agnPsxcinNqEaSyEPKhQ79RRjP8kwtAxGihWWiiPtUBz6PjYgOVTihZokOlRc5sFO9uVSWcuYmqkYnLYSYaWq6MLVd6MBWnbdbiHj8mGutAkBaGnIvpTgkIidDGujAZp2MJmj-q_BM5YOejeSJB058HVgq8FJXQ5MA_X8TS8cjSKozGHnv0ZSs_WBlviOG3cUCB3YtUH5peXp2dH5or1b-knkVJpH-sWLx8RqM918Gah0pVl9sWFP6AAOCJk0 |
linkProvider | Wiley-Blackwell |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1db9MwFL3ah8R4gQ0YZIzNCF5AStc4X84TmqZNZbR7QJu0t8h27a5bl1Rri8R-Pfc6aUoZmgR9iKraVlLnXPvcxD4H4KPVOg11YP2M4yHi1vrSysgPTGKV4hmSYtrv3DtLOhfR6WV8Wa_Nob0wlT5E88CNIsON1xTg9ED6YKEaeq1HsuVmoFVYJ0tvl1F9X6hHicw5n7o4woE4bNRJ-cGi7fJ89IBkPlwr-TuHdZPQyfPKaXXitAtp7clNazZVLX3_h7Ljf_-_TXhW01N2WOFpC1ZM8QKe9OoX8C9hTFLfbHJFxthMGYb0kdU4Ku9-srlCOZMDOUTiyYYIbWSzfYa_j8pi4HDASsskox0VP6oygi-elSwbblU5RkI_HRaMbO-_vIKLk-Pzo45fmzb4GjO92Fd9HQidxdZEWmglhBR9YazGPNTYNFVBkkmt2nFbcSnDFOmUFdwiT5Qxl8rG4TasFWVh3gBTqo9tkkSG3EahTElHhxvMqUVmYxMkHnya37pc14rmZKwxyistZp5TF-auCz340NQdVzoef621O0dAXsfyJOc4KiItQybowfumGKOQXq3IwpSziTPzxA_mvh68rgDTnIZnEVKANrZOl6DUVCCF7-WSYnjllL4Tgd0lIg8-O6Q8cuX56VH30H3b-ZfK-7DROe918-7Xs29v4SmyQVGtRd6FtendzLxDxjVVey6ufgE8USpo |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1bS-QwFD7oCOLLoq6Xes2yvihUp-kthQUZ1EFdFR8cEV9KkiY6y9gOzozgv9-TtFMdFME-lNIkpOTcvjTJdwB2tJSxLz3tJhRvAdXa5ZoHrqciLQRNEBSb886XV9FpJzi_C--m4M_4LEzJD1H_cDOWYf21MfB-pg_eSEP_yR7ftwFoGmYMTR7q9EzrtnPfqT0xS2zqU2tI6In9mp6UHry1ngxIH1Dmx82S70GsjULtefhRwUfSKuW9AFMqX4TZy2qB_Cf0DRU3GTyaxNVEKILwjlRyLp5fyZhBnPAH3kVgSLqoeog2M4Lve0X-YOVECk04MSceXsoyo17Yq0mp8CSKPgLuYTcnJi394RJ02ic3R6dulVTBlTgTC12RSY_JJNQqkEwKxjjLmNIS54lKx7HwooRL0QybgnLuxwh3NKMacRwPKRc69JehkRe5WgUiRIZtooj7VAc-jw3PDVU452WJDpUXObA7HtlUVozjJvFFLy25kmlqpJBaKTjwu67bL3k2Pq21MRZQWtnaIKXotRA2IVJz4FddjFZilj54rorRwCbbxAvnpg6slPKsu6FJgCG6ia3jCUnXFQwD92RJ3n20TNwRw-FigQN7Vie--PL0_OiiZZ_WvlN5G2avj9vpxdnV33WYQ7DGyq3CG9AYPo_UJgKiodiq9P4__P0KUw |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=What+should+be+the+laboratory+approach+against+isolated+prolongation+of+a+activated+partial+thromboplastin+time%3F&rft.jtitle=Journal+of+clinical+laboratory+analysis&rft.au=Falay%2C+Mesude&rft.au=Senes%2C+Mehmet&rft.au=Y%C3%BCcel%2C+Dogan&rft.au=Turhan%2C+Turan&rft.date=2018-07-01&rft.issn=1098-2825&rft.eissn=1098-2825&rft.volume=32&rft.issue=6&rft.spage=e22415&rft_id=info:doi/10.1002%2Fjcla.22415&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0887-8013&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0887-8013&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0887-8013&client=summon |